datavisyn specializes in creating unique data visualization tools and interactive analytic platforms. Our software applications are designed to integrate and interpret complex biomedical or chemical datasets to streamline analytical workflows. Backbone of our products is a unique curated database of public data from 80+ biological, compound, drug, and disease-specific repositories. Targeted at researchers and data scientists in R&D, clinical development, and CMC, these apps unlock visual clarity in scientific data, driving faster decision-making. Our Products: 𝗢𝗿𝗱𝗶𝗻𝗼 | Enabling Discovery: An interactive visual data analysis tool to explore, filter, rank, and visualize large, integrated biomedical datasets. 𝗔𝗲𝘃𝗶𝗱𝗲𝗻𝗰𝗲 | Deep Dive into Target Insights: A suite of specialized apps for scientific discovery, disease understanding, and biomarker development. 𝘃𝗶𝘀𝘆𝗻𝗞𝗻𝗼𝘄𝗹𝗲𝗱𝗴𝗲𝗯𝗮𝘀𝗲 | Data Drives Drug Discovery: A curated database of public data from over 80 biological, compound, drug, and disease-specific repositories. It serves as the backbone for our Ordino and Aevidence applications. In-house experimental data and other sources can be easily integrated on a custom basis. In addition to our core products, datavisyn provides expert services, including the development of new visual analytics and reporting solutions. Founded in 2016 by four leading visual data scientists with roots in top research institutions, including JKU Linz, the University of Utah, the University of Graz, and Harvard University, datavisyn is headquartered in Linz, Austria.
Looking for a particular datavisyn employee's phone or email?
The datavisyn annual revenue was $2 million in 2026.
Michael Pühringer is the CTO of datavisyn.
16 people are employed at datavisyn.
datavisyn is based in Linz, Upper Austria.
The NAICS codes for datavisyn are [54, 541, 5417].
The SIC codes for datavisyn are [87, 873].